E Renard

Summary

Country: France

Publications

  1. doi request reprint Towards an artificial pancreas at home
    E Renard
    Department of Endocrinology, Diabetes, Nutrition, University Hospital of Montpellier, France
    Diabetes Metab 37:S94-8. 2011
  2. pmc Systems medicine and integrated care to combat chronic noncommunicable diseases
    Jean Bousquet
    Department of Respiratory Diseases, Arnaud de Villeneuve Hospital, CHU Montpellier, INSERM CESP U1018, Villejuif, France
    Genome Med 3:43. 2011
  3. doi request reprint Insulin pump use in Europe
    Eric Renard
    Endocrinology Department, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
    Diabetes Technol Ther 12:S29-32. 2010
  4. doi request reprint Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study
    Eric Renard
    Endocrinology Department, Montpellier University Hospital, Montpellier, France
    Diabetes Technol Ther 12:769-73. 2010
  5. ncbi request reprint [From external to implantable insulin pump, can we close the loop?]
    E Renard
    Service des Maladies Endocriniennes, Hopital Lapeyronie, 34295 Montpellier Cedex 5, France
    Diabetes Metab 28:2S19-2S25. 2002
  6. ncbi request reprint [Insulin substitution: new insulins, new modes of delivery]
    Eric Renard
    Service des Maladies Endocriniennes, Hopital Lapeyronie, F34295 Montpellier Cedex 5, France
    J Soc Biol 201:141-8. 2007
  7. ncbi request reprint Implantable insulin pumps. A position statement about their clinical use
    E Renard
    Service des Maladies Endocriniennes, Hopital Lapeyronie, 34295 Montpellier cedex 05, France
    Diabetes Metab 33:158-66. 2007
  8. ncbi request reprint Intensive insulin therapy today: 'basal-bolus' using multiple daily injections or CSII?
    E Renard
    Endocrinology Department, Lapeyronie Hospital, Montpellier, France
    Diabetes Metab 31:4S40-4S44. 2005
  9. ncbi request reprint Implantable continuous glucose sensors
    Eric Renard
    Endocrinology Department, Lapeyronie Hospital, F34295 Montpellier Cedex 5, France
    Curr Diabetes Rev 4:169-74. 2008
  10. ncbi request reprint Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system
    E Renard
    Endocrinology Department, Lapeyronie Hospital, Montpellier, France
    Diabetes Metab 32:497-502. 2006

Collaborators

Detail Information

Publications50

  1. doi request reprint Towards an artificial pancreas at home
    E Renard
    Department of Endocrinology, Diabetes, Nutrition, University Hospital of Montpellier, France
    Diabetes Metab 37:S94-8. 2011
    ..To review the recent clinical research related to the development of an artificial pancreas and the current perspectives for its home use...
  2. pmc Systems medicine and integrated care to combat chronic noncommunicable diseases
    Jean Bousquet
    Department of Respiratory Diseases, Arnaud de Villeneuve Hospital, CHU Montpellier, INSERM CESP U1018, Villejuif, France
    Genome Med 3:43. 2011
    ..This systems medicine strategy, which will take a holistic approach to disease, is designed to allow the results to be used globally, taking into account the needs and specificities of local economies and health systems...
  3. doi request reprint Insulin pump use in Europe
    Eric Renard
    Endocrinology Department, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
    Diabetes Technol Ther 12:S29-32. 2010
    ..More sophisticated technologies connected to pump therapy, such as continuous glucose monitoring or telemedicine, will need specific cost coverage for a true implementation in diabetes care in Europe...
  4. doi request reprint Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study
    Eric Renard
    Endocrinology Department, Montpellier University Hospital, Montpellier, France
    Diabetes Technol Ther 12:769-73. 2010
    ..No recent clinical data on the incidence of catheter-related adverse events under insulin pump therapy have been reported...
  5. ncbi request reprint [From external to implantable insulin pump, can we close the loop?]
    E Renard
    Service des Maladies Endocriniennes, Hopital Lapeyronie, 34295 Montpellier Cedex 5, France
    Diabetes Metab 28:2S19-2S25. 2002
    ....
  6. ncbi request reprint [Insulin substitution: new insulins, new modes of delivery]
    Eric Renard
    Service des Maladies Endocriniennes, Hopital Lapeyronie, F34295 Montpellier Cedex 5, France
    J Soc Biol 201:141-8. 2007
    ....
  7. ncbi request reprint Implantable insulin pumps. A position statement about their clinical use
    E Renard
    Service des Maladies Endocriniennes, Hopital Lapeyronie, 34295 Montpellier cedex 05, France
    Diabetes Metab 33:158-66. 2007
    ..To review clinical use of implantable insulin pumps and to suggest indications for this therapy...
  8. ncbi request reprint Intensive insulin therapy today: 'basal-bolus' using multiple daily injections or CSII?
    E Renard
    Endocrinology Department, Lapeyronie Hospital, Montpellier, France
    Diabetes Metab 31:4S40-4S44. 2005
    ..Nevertheless, individual factors seem to be decisional in the choice between CSII and MDI using long-acting analogues, among which patient ability and will to use an insulin pump are critical...
  9. ncbi request reprint Implantable continuous glucose sensors
    Eric Renard
    Endocrinology Department, Lapeyronie Hospital, F34295 Montpellier Cedex 5, France
    Curr Diabetes Rev 4:169-74. 2008
    ..These data could open a favourable perspective for IGMS after improvement of biointerface conditions and if compatible with an affordable cost...
  10. ncbi request reprint Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system
    E Renard
    Endocrinology Department, Lapeyronie Hospital, Montpellier, France
    Diabetes Metab 32:497-502. 2006
    ..The possibility of implantation of the three crucial components of such a system (insulin delivery device, glucose sensor and controller) is analyzed...
  11. doi request reprint Bariatric surgery in patients with late-stage type 2 diabetes: expected beneficial effects on risk ratio and outcomes
    E Renard
    Endocrinology Department, Centre Hospitalier Universitaire de Montpellier, and UMR CNRS 5232, University of Montpellier I, Montpellier, France
    Diabetes Metab 35:564-8. 2009
    ..The objective of this review was to assess the safety and efficacy of bariatric surgery in patients with severe obesity and late-stage type 2 diabetes (T2D)...
  12. doi request reprint Non-inferiority of insulin glargine versus insulin detemir on blood glucose variability in type 1 diabetes patients: a multicenter, randomized, crossover study
    Eric Renard
    Department of Endocrinology, Diabetes and Nutrition, Montpellier University Hospital and INSERM Clinical Investigation Centre 1001, Lapeyronie University Hospital 191, avenue Doyen Gaston Giraud, Montpellier Cedex 5, France
    Diabetes Technol Ther 13:1213-8. 2011
    ..This study compared the effects of insulin glargine and insulin detemir on blood glucose variability under clinical practice conditions in patients with type 1 diabetes (T1D) using glulisine as the mealtime insulin...
  13. doi request reprint Association of the FTO gene with obesity and the metabolic syndrome is independent of the IRS-2 gene in the female population of Southern France
    R Attaoua
    IURC, Molecular Endocrinology Laboratory UMR 204, Montpellier Cedex 5, France
    Diabetes Metab 35:476-83. 2009
    ..The objective of the present study was to investigate the genetic association of the fat-mass-and-obesity-associated (FTO) gene in obese women in the presence of the known influential role of the insulin receptor substrate 2 (IRS-2) gene...
  14. ncbi request reprint [Insulin therapy in type 1 diabetes for and during pregnancy: by which means and for which objectives?]
    E Renard
    Service des Maladies Endocriniennes, Hopital Lapeyronie, 34295 Montpellier, France
    Diabetes Metab 27:S61-6. 2001
    ..Labor and delivery, cesarean section, fetal maturation by corticosteroids and use of i.v. betamimetic drugs require continuous i.v. insulin delivery. The continuation of intensive insulin management in post-partum is encouraged...
  15. ncbi request reprint [Insulin sensitivity and polycystic ovarian syndrome]
    J Bringer
    Service des Maladies Endocriniennes, , 34295 Montpellier Cedex 5, France
    Diabetes Metab 27:239-45. 2001
    ..Nutritional education and regular physical exercice are the necessary approaches. The efficacy and indications of metformin and thiazolidinediones have to be further evaluated...
  16. doi request reprint Continuous glucose monitoring as a tool to identify hyperglycaemia in non-diabetic patients with acute coronary syndromes
    R P Radermecker
    Endocrinology Department, CHU Montpellier, Universite Montpellier, Montpellier, France
    Diabet Med 26:167-70. 2009
    ..To explore the occurrence and the distribution of glucose excursions > 7.8 mmol/l by continuous glucose monitoring (CGM) in non-diabetic patients admitted with acute coronary syndrome (ACS)...
  17. ncbi request reprint Accuracy of continuous subcutaneous glucose monitoring with the GlucoDay in type 1 diabetic patients treated by subcutaneous insulin infusion during exercise of low versus high intensity
    C Fayolle
    Département de Physiologie Clinique CERAMM, Hopital Lapeyronie, Montpellier, France
    Diabetes Metab 32:313-20. 2006
    ..To validate it when glycaemia may undergo rapid and dramatic changes, we investigated its accuracy during two exercise sessions with markedly different glucose disposal rates...
  18. ncbi request reprint Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome
    S A El Mkadem
    Molecular Endocrinology Laboratory, Institut Universitaire de Recherche Cilnique, Montpellier, France
    Diabetes 50:2164-8. 2001
    ..0085, OR 1.7, 95% CI 1.09-2.99). We conclude that polymorphic alleles of both IRS-1 and IRS-2, alone or in combination, may have a functional impact on the insulin-resistant component of PCOS...
  19. ncbi request reprint Clinical experience with an implanted closed-loop insulin delivery system
    Eric Renard
    Endocrinology Department, Lapeyronie Hospital, Montpellier, France
    Arq Bras Endocrinol Metabol 52:349-54. 2008
    ..To report the first clinical experience with a prototype of implanted artificial beta-cell...
  20. ncbi request reprint [Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring? ]
    E Renard
    Service des Maladies Endocriniennes, Hopital Lapeyronie, 34295 Montpellier Cedex 5, France
    Diabetes Metab 29:S54-62. 2003
    ..Pump control by the sensor signal is conceivable if it corresponds to a direct, continuous, real time measurement of blood glucose, and subject to a simultaneous improvement of insulin infusion modes...
  21. ncbi request reprint [Long-term risks of polycystic ovaries syndrome]
    P Lefebvre
    Service des Maladies Endocriniennes, Hopital Lapeyronie, 371, avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France
    Gynecol Obstet Fertil 32:193-8. 2004
    ..The latter begin to be better understood. Some studies suggest that PCOS may increase the risk for several conditions, including type 2 diabetes, dyslipidemia, hypertension, cardiovascular disease and some cancers...
  22. ncbi request reprint Syndrome of body fat redistribution in HIV-1-infected patients: relationships to cortisol and catecholamines
    E Renard
    The Department of Endocrinology, Lapeyronie Hospital, Montpellier, France
    Clin Endocrinol (Oxf) 51:223-30. 1999
    ..Alterations of body fat distribution have been recently reported in HIV-infected patients. We aimed to investigate whether the hormones modulating adipose tissue metabolism could be implicated...
  23. doi request reprint Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion
    R P Radermecker
    Division of Diabetes, Nutrition and Metabolic Disorders, CHU Liege, University of Liege, Liege, Belgium
    Diabetes Metab 39:258-62. 2013
    ..For this reason, this study assessed whether such a goal could be reached with a subcutaneous 'needle-type' enzymatic sensor...
  24. ncbi request reprint [Which contraception to choose for the diabetic woman?]
    J Bringer
    Service des Maladies Endocriniennes, Hopital Lapeyronie, 34295 Montpellier
    Diabetes Metab 27:S35-41. 2001
    ..Macroprogestative contraception is a adequate choice for women within forties. For multiparous diabetic women, intra-uterine devices represent the first choice...
  25. doi request reprint Optimizing the outcome of pregnancy in obese women: from pregestational to long-term management
    F Galtier
    Inserm CIC 0001, Clinical Investigation Centre, St Eloi hospital, Montpellier University Hospital, 80, avenue Augustin Fliche, 34295 Montpellier cedex 05, France
    Diabetes Metab 34:19-25. 2008
    ....
  26. ncbi request reprint Dupuytren's disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus
    M Chammas
    Department of Endocrinology, Lapeyronie University Hospital, Montpellier, France
    J Hand Surg Am 20:109-14. 1995
    ..All these hand changes were more marked in insulin-dependent diabetics and they showed a positive correlation with increasing age of the patient, duration of the diabetes, and the presence of a microangiopathy...
  27. ncbi request reprint Myocardial perfusion imaging and cardiac events in a cohort of asymptomatic patients with diabetes living in southern France
    A Sultan
    Metabolic Diseases Department, Montpellier University Hospital, Montpellier, France
    Diabet Med 23:410-8. 2006
    ..Predictors of abnormal stress MPI were also evaluated...
  28. ncbi request reprint Resting energy expenditure and fuel metabolism following laparoscopic adjustable gastric banding in severely obese women: relationships with excess weight lost
    F Galtier
    centre d investigation clinique, Hopital St Eloi, Montpellier Cedex, France
    Int J Obes (Lond) 30:1104-10. 2006
    ....
  29. pmc Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas
    Eric Renard
    Endocrinology Department, Le Centre Hospitalier Universitaire Montpellier, Montpellier, France
    Diabetes Care 33:121-7. 2010
    ..We tested closed-loop intraperitoneal insulin infusion from an implanted pump driven by an subcutaneous glucose sensor via a proportional-integral-derivative (PID) algorithm...
  30. doi request reprint A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects
    Hugues Chevassus
    centre d investigation clinique, Centre Hospitalier Régional Universitaire de Montpellier, Montpellier, France
    Eur J Clin Pharmacol 66:449-55. 2010
    ..The aim of our study was to investigate the effects of a repeated administration of a fenugreek seed extract on the eating behaviour of overweight subjects...
  31. ncbi request reprint Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy
    Eric Renard
    Department of Endocrinology, Lapeyronie Hospital, 34295, Cedex 5, Montpellier, France
    Curr Opin Pharmacol 2:708-16. 2002
    ..Preliminary investigations of intravascular enzymatic sensors demonstrate their clinical acceptability and accuracy and the possibility of developing closed-loop insulin delivery by combination with implantable pumps...
  32. pmc The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance
    Patricia Aguilar-Martinez
    CHU of Montpellier Laboratory of Hematology, Hopital Saint Eloi, avenue Augustin Fliche, 34295 Montpellier Cedex 5, France
    Haematologica 95:551-6. 2010
    ..Despite great progress in understanding the mechanisms underlying genetic hemochromatosis, data on the prevalence and the penetrance of the disorder are conflicting...
  33. ncbi request reprint Implantable insulin pumps: infections most likely due to seeding from skin flora determine severe outcomes of pump-pocket seromas
    E Renard
    Department of Endocrinology, Lapeyronie Hospital, Montpellier, France
    Diabetes Metab 27:62-5. 2001
    ..We recommend that bacterial investigations of pump-pocket seromas should be systematically performed, while prophylactic measures might include antibiotic cover for each puncture of the pump-pocket...
  34. ncbi request reprint Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia
    G J Thöni
    UPRES EA 2991, Sports, Performance, Health Laboratory, Faculty of Sport Sciences, Montpellier, France
    Diabetes Metab 28:397-404. 2002
    ..The management of abdominal fat accumulation and metabolic disorders in HIV1-infected patients, by an aerobic training program, is considered...
  35. ncbi request reprint Monitoring glycemic control: the importance of self-monitoring of blood glucose
    Eric Renard
    Department of Endocrinology, Diabetes, and Metabolism, Montpellier I University, Montpellier, France
    Am J Med 118:12S-19S. 2005
    ..SMBG should be implemented for all patients as part of an overall diabetes management plan that includes specific instruction on how, when, and why to test...
  36. doi request reprint [Cowden syndrome, or multiple hamartomatous tumor syndrome, in clinical endocrinology]
    M Sardinoux
    Service des Maladies Endocriniennes, Hopital Lapeyronie, CHRU de Montpellier, 371, avenue du Doyen Gaston Giraud, 34925 Montpellier cedex 05, France
    Ann Endocrinol (Paris) 71:264-73. 2010
    ..The development of antineoplastic agents targeting PI3K/Akt/mTOR pathway, such as rapamycin, may be the opportunity of treatment in PHTS and CS patients, for whom no specific medical treatment exist...
  37. pmc Effects of oral monosodium (L)-glutamate on insulin secretion and glucose tolerance in healthy volunteers
    Hugues Chevassus
    Section of Clinical Pharmacology, Clinical Investigation Center, Saint Eloi University Hospital, and Research Unit UPRES EA 1677, Faculty of Medicine, Montpellier, France
    Br J Clin Pharmacol 53:641-3. 2002
    ..To investigate the effects of glutamate on insulin secretion and glucose tolerance in humans...
  38. doi request reprint Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials
    P Y Benhamou
    Department of Endocrinology, Centre Hospitalier Universitaire de Grenoble, Pôle DigiDUNE, Clinique d Endocrinologie, BP 217X, Grenoble 38043, France
    Diabet Med 26:617-21. 2009
    ..Rigorous assessment of health-related quality of life (HRQL) is mandatory to establish the benefits of islet transplantation...
  39. ncbi request reprint Identification of two novel insulin receptor mutations, Asp59Gly and Leu62Pro, in type A syndrome of extreme insulin resistance
    M Rouard
    Laboratoire d Endocrinologie Moléculaire, Institut Universitaire de Recherche Clinique and Centre de Recherche de Biochimie Macromoléculaire, ERS 155 CNRS, Montpellier, France
    Biochem Biophys Res Commun 234:764-8. 1997
    ....
  40. ncbi request reprint Risk factors for silent myocardial ischemia in high-risk type 1 diabetic patients
    Ariane Sultan
    Metabolic Diseases Department, Montpellier University Hospital, Montpellier, France
    Diabetes Care 27:1745-7. 2004
  41. ncbi request reprint Global sequencing approach for characterizing the molecular background of hereditary iron disorders
    Severine Cunat
    Laboratory of Haematology, CHU of Montpellier, Montpellier, France
    Clin Chem 53:2060-9. 2007
    ..This study aimed to develop a rapid automated method for sequencing the main genes involved...
  42. doi request reprint Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes
    John C Pickup
    Metabolic Unit, King s College London School of Medicine, Guy s Hospital, London SE1 9RT, UK
    Diabetes Care 31:S140-5. 2008
    ..It is possible that CSII will be beneficial in selected patient groups with type 2 diabetes, but this requires further study...
  43. ncbi request reprint Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial
    Lionel Badet
    Department of Urology, University Hospital, Lyon, France
    Transplantation 84:89-96. 2007
    ....
  44. ncbi request reprint [Treatment of insulin-dependent diabetes: new therapy by electromagnetic replacement: towards an artificial pancreas]
    Jacques Bringer
    CHU Hôpital Lapeyronie, 371 avenue du doyen Gaston Géraud 34295 Montpellier
    Bull Acad Natl Med 187:1285-94; discussion 1295. 2003
    ..This most physiological restoration of insulin function is feasible and appears to represent a possibility for long term treatment of diabetics...
  45. ncbi request reprint Implantable pump therapy restores metabolic control and quality of life in type 1 diabetic patients with Buschke's nonsystemic scleroderma
    Sabine Baillot-Rudoni
    Diabetes Care 29:1710. 2006
  46. ncbi request reprint French multicentric survey of outcome of pregnancy in women with pregestational diabetes
    Pierre Boulot
    Diabetes Care 26:2990-3. 2003
    ..To evaluate perinatal outcome in pregnancies in women with type 1 and type 2 diabetes and the influence of preconception care 10 years after the St. Vincent's declaration...
  47. ncbi request reprint Logistics and transplant coordination activity in the GRAGIL Swiss-French multicenter network of islet transplantation
    Marie Claude Kempf
    Department of Surgery, Geneva University Hospitals, Geneva, Switzerland
    Transplantation 79:1200-5. 2005
    ..Some institutions have elected to associate in multicenter networks, such as the Swiss-French GRAGIL (Groupe Rhin-Rhône-Alpes-Genève pour la Transplantation d'Ilots de Langerhans) consortium...
  48. ncbi request reprint Naltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disorders
    Isabelle Raingeard
    Diabetes Care 27:847-8. 2004
  49. ncbi request reprint Aseptic peritonitis revealed through recurrent catheter obstructions in type 1 diabetic patients treated with continuous peritoneal insulin infusion
    Eric Renard
    Diabetes Care 27:276-7. 2004
  50. ncbi request reprint Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation
    Corinne Lautier
    Molecular Endocrinology Laboratory, University Institute of Clinical Research, Faculty of Medicine, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France
    Hum Genet 113:34-43. 2003
    ....